News & Perspective

Jan 19, 2012

Jan 19, 2012

Review renews questions about oseltamivir benefits

(CIDRAP News) – A lengthy new analysis of unpublished clinical trial data is renewing questions about the effectiveness of the influenza drug oseltamivir (Tamiflu), saying that although the drug shortens flu symptoms by about a day, there is no evidence that it reduces hospital admissions.

Apr 26, 2010

Apr 26, 2010

H1N1 LESSONS LEARNED Vaccine production foiled, confirmed experts' predictions

Second in a series marking the 1-year anniversary of novel H1N1 pandemic influenza. The first, on the virus itself, appeared Apr 23.

Oct 30, 2009

Oct 30, 2009

WHO experts favor single-dose H1N1 vaccine regimen

(CIDRAP News) – An expert committee that advises the World Health Organization (WHO) today updated its guidance on pandemic H1N1 vaccines, recommending a single dose for most age-groups and advising that any of the forms are safe for pregnant women.

Oct 22, 2009

Oct 22, 2009

CDC notes change in ethnic pattern of H1N1 impact

(CIDRAP News) – The Centers for Disease Control (CDC) has seen a change in the ethnic distribution of fatal pandemic H1N1 influenza cases, a CDC official reported at a meeting of its vaccine advisory committee today.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»